We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

36 hedge funds and large institutions have $5.76M invested in Pear Therapeutics, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital invested

Capital invested by funds: $3.67M → $5.76M (+$2.08M)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

3% less funds holding

Funds holding: 37 → 36 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
4
Calls
$131K
Puts
–
Net Calls
+$131K
Net Calls Change
-$420K

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$110K
2
LP
LMR Partners
United Kingdom
+$73.3K
3
QGA
Q Global Advisors
Texas
+$36.6K
4
OMC
Old Mission Capital
Illinois
+$2.58K
5
SG
StoneX Group
New York
+$1.47K

Top Sellers

Rank Fund Capital Flow
1
MA
MYDA Advisors
New York
-$9K
2
HF
HRT Financial
New York
-$2K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1K
4
AR
Advisory Research
Illinois
-$830
5
UBS Group
UBS Group
Switzerland
-$748
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$4.98M +$73.3K +500,000 +26%
Walleye Capital
2
Walleye Capital
New York
$130K +$110K +749,551 +4,201%
OCAM
3
Owl Creek Asset Management
New York
$70K – – –
AGC
4
Angelo Gordon & Co
New York
$68K – – –
HCM
5
Highbridge Capital Management
New York
$67K – – –
QGA
6
Q Global Advisors
Texas
$45K +$36.6K +250,000 New
BlackRock
7
BlackRock
New York
$40K – – –
AR
8
Advisory Research
Illinois
$35K -$830 -5,660 -3%
SC
9
Sculptor Capital
New York
$32K – – –
SRF
10
Silver Rock Financial
California
$32K – – –
KC
11
Kepos Capital
New York
$28K – – –
MCM
12
Moore Capital Management
New York
$28K – – –
DCM
13
Difesa Capital Management
New York
$26K – – –
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$25K – – –
AI
15
Arena Investors
New York
$21.4K – – –
TCA
16
Taconic Capital Advisors
New York
$17K – – –
TI
17
Telemetry Investments
New York
$15K – – –
Citadel Advisors
18
Citadel Advisors
Florida
$13K -$15 -100 -0.1%
DKCM
19
Davidson Kempner Capital Management
New York
$12K – – –
PI
20
PEAK6 Investments
Illinois
$11K – – –
WCMNY
21
Westchester Capital Management (New York)
New York
$11K – – –
CCA
22
Castle Creek Arbitrage
Colorado
$10K – – –
Hudson Bay Capital Management
23
Hudson Bay Capital Management
Connecticut
$9K – – –
KL
24
KIM LLC
Kansas
$6K – – –
TCM
25
Tenor Capital Management
New York
$6K – – –
1
2

PEARW Hedge Fund Activity: Q3 2022 in Review

36 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q3 2022, worth a combined $5.76M — up 57% from $3.67M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PEARW and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Walleye Capital, adding an estimated $110K. The largest seller was MYDA Advisors, exiting entirely with an estimated $9K sold.

  • 36 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q3 2022, down from 37 in Q2 2022.
  • Funds reported $5.76M of Pear Therapeutics, Inc. Warrant stock for Q3 2022, up 57% quarter-over-quarter.
  • 3 funds opened new Pear Therapeutics, Inc. Warrant positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q3 2022 was Walleye Capital, an estimated $110K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q3 2022 was MYDA Advisors, an estimated $9K sold.

Based on aggregated 13F filings for Q3 2022.